Trexquant Investment LP Rhythm Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$15.81 - $27.8 $387,566 - $681,489	24,514 New	24,514 $561,000
Q2 2021 Aug 12, 2021	SELL	$18.52 - $22.55 $213,628 - $260,114	-11,535 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$20.25 - $39.49 $233,583 - $455,517	11,535 New	11,535 $245,000
Q3 2018 Nov 09, 2018	SELL	$26.99 - $35.85 $349,520 - $464,257	-12,950 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$17.02 - $35.2 $220,409 - $455,840	12,950 New	12,950 $405,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.